Variation in PPARG is associated with longitudinal change in insulin resistance in Mexican Americans at risk for type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 3, 2015, Pages 1187-1195

  Black, Mary Helen ^a   Wu, Jun ^a   Takayanagi, Miwa ^a   Wang, Nan ^b   Taylor, Kent D ^c   Haritunians, Talin ^c   Trigo, Enrique ^b   Lawrence, Jean M ^a   Watanabe, Richard M ^b   Buchanan, Thomas A ^b   Xiang, Anny H ^a  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ALANINE; PROLINE;

ADULT; ARTICLE; BODY FAT; DOWN REGULATION; DUAL ENERGY X RAY ABSORPTIOMETRY; EXON; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC TRAIT; GENETIC VARIABILITY; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRON; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEXICAN AMERICAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PHENOTYPE; PPARG GENE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; AMINO ACID SUBSTITUTION; CROSS-SECTIONAL STUDY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; YOUNG ADULT;

ADULT; ALANINE; AMINO ACID SUBSTITUTION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MALE; MEXICAN AMERICANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; PROLINE; YOUNG ADULT;

EID: 84924943297     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-3246     Document Type: Article

References (45)

1. Fajas L, Auboeuf D, Raspé E, et al. The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem. 1997;272:18779-18789.
2. Deeb SS, Fajas L, Nemoto M, et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998; 20:284-287.
3. Cole SA, Mitchell BD, Hsueh WC, et al. The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans. Int J Obes Relat Metab Disord. 2000;24:522-524.
4. Robitaille J, Després JP, Pérusse L, Vohl MC. The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: Results from the Québec Family Study. Clin Genet. 2003;63:109-116.
5. Kim KS, Choi SM, Shin SU, Yang HS, Yoon Y. Effects of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala polymorphism on body fat distribution in female Korean subjects. Metabolism. 2004;53:1538-1543.
6. Wei Q, Jacobs DR Jr, Schreiner PJ, Siscovick DS, Steffes MW, Fornage M. Patterns of association between PPARgamma genetic variation and indices of adiposity and insulin action in African-Americans and whites: The CARDIA Study. J Mol Med (Berl). 2006;84:955-965.
7. Dongxia L, Qi H, Lisong L, Jincheng G. Association of peroxisome proliferator-activated receptorgamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome. Circ J. 2008;72:551-557.
8. Bhatt SP, Misra A, Sharma M, Luthra K, Guleria R, Pandey RM, Vikram NK. Ala/Ala genotype of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ2 gene is associated with obesity and insulin resistance in Asian Indians. Diabetes Technol Ther. 2012;14:828-834.
9. Prakash J, Srivastava N, Awasthi S, et al. Association of PPAR-γ gene polymorphisms with obesity and obesity-associated phenotypes in North Indian population. Am J Hum Biol. 2012;24:454-459.
10. Douglas JA, Erdos MR, Watanabe RM, et al. The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: Association with type 2 diabetes and trait differences. Diabetes. 2001;50:886-890.
11. Mori Y, Kim-Motoyama H, Katakura T, et al. Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men. Biochem Biophys Res Commun. 1998;251:195-198.
12. Clement K, Hercberg S, Passinge B, et al. The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes. Int J Obes Relat Metab Disord. 2000;24:391-393.
13. Meirhaeghe A, Fajas L, Helbecque N, et al. Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord. 2000;24:195-199.
14. Evans D, Wolf AM, Nellessen U, et al. Association between polymorphisms in candidate genes and morbid obesity. Int J Obes Relat Metab Disord. 2001;25(Suppl 1):S19-S21.
15. Frederiksen L, Brodbaek K, Fenger M, et al. Comment: Studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: Homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab. 2002;87:3989-3992.
16. Nelson TL, Fingerlin TE, Moss L, Barmada MM,Ferrell RE, Norris JM. The PPARgamma Pro12Ala polymorphism is not associated with body mass index or waist circumference among Hispanics from Colorado. Ann Nutr Metab. 2007;51:252-257.
17. Lindi V, Sivenius K, Niskanen L, Laakso M, Uusitupa MI. Effect of the Pro12Ala polymorphism of the PPAR-gamma2 gene on longterm weight change in Finnish non-diabetic subjects. Diabetologia. 2001;44:925-926.
18. Nicklas BJ, van Rossum EF, Berman DM, Ryan AS, Dennis KE, Shuldiner AR. Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes. 2001;50:2172-2176.
19. Franks PW, Jablonski KA, Delahanty L, et al. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia. 2007;50:2451-2460.
20. Fornage M, Jacobs DR, Steffes MW, et al. Inverse effects of the PPAR(gamma)2 Pro12Ala polymorphism on measures of adiposity over 15 years in African Americans and whites. The CARDIA study. Metabolism. 2005;54:910-917.
21. Matsuo T, Nakata Y, Katayama Y, et al. PPARG genotype accounts for part of individual variation in body weight reduction in response to calorie restriction. Obesity (Silver Spring). 2009;17:1924-1931.
22. Delahanty LM, Pan Q, Jablonski KA, et al. Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program. Diabetes Care. 2012;35:363-366.
23. Jaziri R, Lobbens S, Aubert R, et al. The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: The Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study. Diabetes. 2006;55:1157-1162.
24. Black MH, Fingerlin TE, Allayee H, et al. Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans. Diabetes. 2008;57:1048-1056.
25. Xiang AH, Takayanagi M, Black MH, et al. Longitudinal changes in insulin sensitivity and beta cell function between women with and without a history of gestational diabetes mellitus. Diabetologia. 2013;56:2753-2760.
26. Lange K, Papp JC, Sinsheimer JS, Sripracha R, Zhou H, Sobel EM. Mendel: The Swiss army knife of genetic analysis programs. Bioinformatics. 2013;29:1568-1570.
27. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62:1198-1211.
28. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-265.
29. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science. 2002;296:2225-2229.
30. Abecasis GR, Auton A, Brooks LD, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56-65.
31. Alexander DH, Lange K. Enhancements to the ADMIXTURE algorithm for individual ancestry estimation. BMC Bioinformatics. 2011;12:246.
32. Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN. MINMOD Millennium: A computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther. 2003;5:1003-1015.
33. Bergman RN. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes. 1989;38:1512-1527.
34. Rosner B. 1993 Fundamentals of biostatistics. In: Biometrical Journal. 5th ed. Boston: Brooks/Cole, Cengage Learning; 150-150.
35. Doney A, Fischer B, Frew D, et al. Haplotype analysis of the PPAR-gamma Pro12Ala and C1431T variants reveals opposing associations with body weight. BMC Genet. 2002;3:21.
36. Meirhaeghe A, Fajas L, Gouilleux F, et al. A functional polymorphism in a STAT5B site of the human PPAR gamma3 gene promoter affects height and lipid metabolism in a French population. Arterioscler Thromb Vasc Biol. 2003;23:289-294.
37. Tai ES, Corella D, Deurenberg-Yap M, et al. Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population. J Lipid Res. 2004;45:674-685.
38. Meirhaeghe A, Cottel D, Amouyel P, Dallongeville J. Association between peroxisome proliferator-activated receptor gamma haplotypes and the metabolic syndrome in French men and women. Diabetes. 2005;54:3043-3048.
39. Haseeb A, Iliyas M, Chakrabarti S, et al. Single-nucleotide polymorphisms in peroxisome proliferator-activated receptor gamma and their association with plasma levels of resistin and the metabolic syndrome in a South Indian population. J Biosci. 2009;34:405-414.
40. Nica AC, Parts L, Glass D, et al. The architecture of gene regulatory variation across multiple human tissues: The MuTHER study. PLoS Genet. 2011;7:e1002003.
41. Grundberg E, Small KS, Hedman ÅK, et al. Mapping cis- and transregulatory effects across multiple tissues in twins. Nat Genet. 2012; 44:1084-1089.
42. Karolchik D, Barber GP, Casper J, et al. The UCSC Genome Browser database: 2014 update. Nucleic Acids Res. 2014;42:D764-D770.
43. Rosenbloom KR, Sloan CA, Malladi VS, et al. ENCODE data in the UCSC Genome Browser: Year 5 update. Nucleic Acids Res. 2013;41:D56-D63.
44. Duran-Gonzalez J, Ortiz I, Gonzales E, et al. Association study of candidate gene polymorphisms and obesity in a young Mexican-American population from South Texas. Arch Med Res. 2011;42:523-531.
45. Martínez-Gómez LE, Cruz M, Martínez-Nava GA, et al. A replication study of the IRS1, CAPN10, TCF7L2, and PPARG gene polymorphisms associated with type 2 diabetes in two different populations of Mexico. Ann Hum Genet. 2011;75:612-620.